ReviewInfection and drug resistance2025
Characteristics of HPV Infection in Women Cervical and Anal with HIV-Infected and the Advances in Epidemiological Research.
Review in Infection and drug resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Evaluation of Antiproliferative Activity and Molecular Modeling Studies of Some Novel Benzimidazolone-Bridged Hybrid Compounds.Pharmaceuticals (Basel, Switzerland) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antiretroviral therapy (ART) has significantly reduced the incidence and mortality of AIDS-related diseases, bringing the life expectancy of human immunodeficiency virus (HIV)-infected individuals close to that of uninfected individuals. However, the incidence and mortality rates of tumors associated with human papillomavirus (HPV) have not decreased. Persistent infection with high-risk HPV is a major cause of cervical cancer and other related malignancies, and the risk of HPV infection and the incidence of related diseases are higher among HIV-infected individuals. Although the World Health Organization provides screening recommendations for the general population, there is a lack of guidelines for cervical and anal cancer screening specifically in HIV-positive patients. Further research is urgently needed to develop effective preventive measures. This article reviews the epidemiological characteristics and associations of HPV infections and related cancers in HIV-infected women, providing reference for prevention and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.